Comparative efficacy and safety of cefprozil (BMY-28100) and cefaclor in the treatment of acute group A beta-hemolytic streptococcal pharyngitis.

Cefprozil (BMY-28100) is a semisynthetic cephalosporin with broad-spectrum antibacterial activity and prolonged serum elimination half-life allowing for once-a-day oral administration. In vitro, cefprozil demonstrates excellent activity against Staphylococcus aureus, Streptococcus pyogenes, Haemophi...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Christenson, J C, Swenson, E, Gooch, W M, Herrod, J N
Natura: Artigo
Lingua:Inglês
Pubblicazione: 1991
Soggetti:
Research Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC284298/
https://ncbi.nlm.nih.gov/pubmed/1929253
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi